Search

everythinglearnresearchcommunity

for

Search:↓

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Skin cancer often starts from Lgr5+ progenitor cells.

U.S. dermatology residents need more education and experience with LGBT patients to improve their cultural competency.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Vimentin is involved in regulating the hair growth cycle in Inner Mongolian Cashmere goats.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Kawasaki's disease can occur in adults and should be considered with specific symptoms and high ferritin levels.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.

Fusidic acid successfully treated a rare scalp infection with hair regrowth and no recurrence after 6 months.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

Long COVID causes lasting symptoms and needs ongoing care.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Topical tofacitinib is effective and safe for treating alopecia areata.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.